Trial Profile
Effects of TNF-alpha [tumour necrosis factor-alpha] antagonism in patients with the metabolic syndrome (I)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Insulin resistance; Metabolic syndrome
- Focus Pharmacodynamics
- 18 Dec 2006 New trial record.